Clinical trial
Noninvasive Spinal Cord Neuromodulation to Enhance Motor Function in Individuals With Hereditary Spastic Paraplegia
NCT07417943 is registered in ClinicalTrials.gov with Rahul Sachdeva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Spinal Cord Neuromodulation to Enhance Motor Function in Individuals With Hereditary Spastic Paraplegia
- Lead sponsor
- Rahul Sachdeva
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 9, 2026
- Completion date
- February 1, 2028
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hereditary spastic paraplegia